Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
Endocrine Oncology · 01.07.2022 · 2 (1) · R65-R77
DOI: 10.1530/eo-22-0044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Oncology, erschienen am 01.07.2022. Verfasst von Christie G Turin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are neuroendocrine tumors arising from the adrenal medulla and extra-adrenal ganglia, respectively. Approximately 15–25% of PCC/PGL can become metastatic. Up to 30–40% of patients with PCC/PGL have a germline pathogenic variant in a known susceptibility gene for PCC/PGL; therefore, all patients with PCC/PGL should undergo clinical genetic testing. Most of the susceptibility genes are associated with variable penetrance for PCC/PGL and are associated with different syndromes, which include susceptibility for other tumors and conditions. The objective of this review is to provide an overview of the germline susceptibility genes for PCC/PGL, the associated clinical syndromes, and recommended surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA.
- Department of Pediatrics, Combined Pediatrics-Medical Genetics Residency Program, University of Colorado, Aurora, Colorado, USA.
- Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Christie G Turin, Lauren Fishbein
Förderung
- NCI NIH HHS
Zitieren
APA
Turin, C. G., Crenshaw, M. M., & Fishbein, L. (2022). Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes. Endocrine Oncology, 2(1), R65-R77. https://doi.org/10.1530/eo-22-0044
Vancouver
Turin CG, Crenshaw MM, Fishbein L. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes. Endocrine Oncology. 2022;2(1):R65-R77. doi:10.1530/eo-22-0044
BibTeX
@article{Turin2022,
author = {Turin, Christie G and Crenshaw, Molly M and Fishbein, Lauren},
title = {Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes},
journal = {Endocrine Oncology},
year = {2022},
volume = {2},
number = {1},
pages = {R65--R77},
doi = {10.1530/eo-22-0044}
}
EUVIMED